Patents Assigned to Research Triangle Institute
  • Patent number: 7071204
    Abstract: Camptothecin analogs having an E-ring ketone are effective anti tumor compounds. These compounds inhibit the enzyme topoisomerase I and may alkylate DNA of the associated topoisomerase I DNA cleavable complex.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: July 4, 2006
    Assignee: Research Triangle Institute
    Inventors: Michael A. Wall, Mansukh C. Wani, Govindarajan Manikumar, Monroe E. Wall
  • Patent number: 7067666
    Abstract: Methods of forming camptothecin compounds which are effective anti-tumor compounds are disclosed. These compounds inhibit the enzyme topoisomerase I and may alkylate DNA of the associated topoisomerase I-DNA cleavable complex.
    Type: Grant
    Filed: June 27, 2003
    Date of Patent: June 27, 2006
    Assignee: Research Triangle Institute
    Inventors: Mansukh C. Wani, Govindarajan Manikumar, Michael A. Wall, Monroe E. Wall
  • Patent number: 7067093
    Abstract: Reduced sulfur gas species (e.g., H2S, COS and CS2) are removed from a gas stream by compositions wherein a zinc titanate ingredient is associated with a metal oxide-aluminate phase material in the same particle species. Nonlimiting examples of metal oxides comprising the compositions include magnesium oxide, zinc oxide, calcium oxide, nickel oxide, etc.
    Type: Grant
    Filed: March 2, 2004
    Date of Patent: June 27, 2006
    Assignees: Research Triangle Institute, Intercat, Inc.
    Inventors: Albert A. Vierheilig, Raghubir P. Gupta, Brian S. Turk
  • Patent number: 7058638
    Abstract: A method and system for ensuring statistical disclosure limitation (SDL) of categorical or continuous micro data, while maintaining the analytical quality of the micro data. The new SDL methodology exploits the analogy between (1) taking a sample (instead of a census,) along with some adjustments, including imputation, for missing information, and (2) releasing a subset, instead of the original data set, along with some adjustments for records still at disclosure risk. Survey sampling reduces monetary cost in comparison to a census, but entails some loss of information. Similarly, releasing a subset reduces disclosure cost in comparison to the full database, but entails some loss of information. Thus, optimal survey sampling methods can be used for statistical disclosure limitation. The method includes partitioning the database into risk strata, optimal probabilistic substitution, optimal probabilistic subsampling, and optimal sampling weight calibration.
    Type: Grant
    Filed: September 3, 2002
    Date of Patent: June 6, 2006
    Assignee: Research Triangle Institute
    Inventor: Avinash C. Singh
  • Patent number: 7042306
    Abstract: Three dimensional electronic and optical coupling devices that are capable of providing high speed coupling over a large frequency range while limiting the amount of space consumption in the communications network. An optical or electrical coupling device comprises a first substrate and a second substrate adjacent to the first substrate having one or more optical waveguides or microstrips formed thereon. The substrates will have disposed thereon conductive microstrips and/or dielectric elements. The one or more optical waveguides or microstrips formed on the first substrate correspond to at least one optical waveguides or microstrips formed on the second substrate so as to facilitate optical coupling between the corresponding waveguides. Precise spacing between the substrates and precise spacing between the optical waveguides or microstrips facilitate the requisite optical/RF coupling.
    Type: Grant
    Filed: July 7, 2004
    Date of Patent: May 9, 2006
    Assignee: Research Triangle Institute
    Inventors: Mark W. Roberson, Philip A. Deane, Charles Kenneth Williams
  • Patent number: 7026602
    Abstract: The present invention provides for an improved electromagnetic radiation detector having a micromachined electrostatic chopper/shutter device. The MEMS flexible film chopper/shutter device provides reliability, efficiency, noise reduction and temperature fluctuation compensation capabilities to the associated electromagnetic radiation detector. An electromagnetic radiation detector having an electrostatic chopper/shutter device includes a detector material element and flexible film actuator overlying the detector material layer and moveable relative thereto. The flexible film actuator will typically include an electrode element and a biasing element such that the actuator remains in a fully curled, open state absent electrostatic voltage and moves to a fully uncurled, closed state upon the application of electrostatic voltage. Arrays that incorporate a plurality of electromagnetic radiation detectors and/or electrostatic shuttering devices are additionally provided for.
    Type: Grant
    Filed: May 29, 2003
    Date of Patent: April 11, 2006
    Assignee: Research Triangle Institute
    Inventor: David E. Dausch
  • Patent number: 7018991
    Abstract: The invention is directed to a novel class of steroids which exhibit potent antiprogestational activity.
    Type: Grant
    Filed: July 2, 2003
    Date of Patent: March 28, 2006
    Assignee: Research Triangle Institute
    Inventors: C. Edgar Cook, John A. Kepler, Gary S. Bartley, Rupa S. Shetty
  • Patent number: 7011813
    Abstract: Tropane derivatives having a high binding affinity and selectivity for dopamine transporters bear, on the tropane backbone either a carboxylic ester or isoxazole moiety, as well as a substituted phenyl moiety. The compounds have utility both as pharmaceutical and as imaging agents, when one or more atoms are radioactive.
    Type: Grant
    Filed: May 28, 2002
    Date of Patent: March 14, 2006
    Assignee: Research Triangle Institute
    Inventors: Michael J. Kuhar, Frank Ivy Carroll, John W. Boja, Anita H. Lewin, Philip Abraham
  • Patent number: 6974824
    Abstract: Kappa opioid receptor antagonists are provided that yield significant improvements in functional binding assays to kappa opioid receptors relative to nor-BNI, and the use of these antagonists in treatment of disease states that are ameliorated by binding of the kappa opioid receptor such as heroin or cocaine addictions.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: December 13, 2005
    Assignee: Research Triangle Institute
    Inventors: F. Ivy Carroll, James B. Thomas, S. Wayne Mascarella
  • Patent number: 6972889
    Abstract: A simplified MEMS optical display device driven by electrostatic forces and associated arrays are provided for. The optical display device includes an optically transparent substrate, an optically transparent fixed electrode disposed on the substrate and a pigmented translucent film disposed on the substrate. A moveable optical shutter is affixed to the substrate and is generally aligned with the fixed electrode and the pigmented translucent film. The moveable optical shutter comprises an electrode element and a biasing element. In addition, a fixed portion attached to the substrate and a distal portion adjacent to the fixed portion defines the optical shutter. When an electrostatic voltage differential is established between the fixed electrode and the optical shutter electrode element the distal portion of the optical shutter will move to controllably regulate the pigmentation of an optical signal.
    Type: Grant
    Filed: June 27, 2002
    Date of Patent: December 6, 2005
    Assignee: Research Triangle Institute
    Inventors: Scott H. Goodwin-Johansson, Brian H. Augustine, Lindsey N. Yadon
  • Patent number: 6962683
    Abstract: A method is provided for removal of sulfur gases and recovery of elemental sulfur from sulfur gas containing supply streams, such as syngas or coal gas, by contacting the supply stream with a catalyst, that is either an activated carbon or an oxide based catalyst, and an oxidant, such as sulfur dioxide, in a reaction medium such as molten sulfur, to convert the sulfur gases in the supply stream to elemental sulfur, and recovering the elemental sulfur by separation from the reaction medium.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: November 8, 2005
    Assignee: Research Triangle Institute
    Inventors: Santosh K. Gangwal, Apostolos A. Nikolopoulos, Mary Anne Dorchak, Thomas P. Dorchak
  • Publication number: 20050224999
    Abstract: Apparatus and method for producing fibrous materials in which the apparatus includes an extrusion element configured to electrospin a substance from which the fibers are to be composed by an electric field extraction of the substance from a tip of the extrusion element, a collector disposed from the extrusion element and configured to collect the fibers, a chamber enclosing the collector and the extrusion element, and a control mechanism configured to control a gaseous environment in which the fibers are to be electrospun. The method includes providing a substance from which the fibers are to be composed to a tip of an extrusion element, applying an electric field to the extrusion element in a direction of the tip, controlling a gaseous environment about where the fibers are to be electrospun, and electrospinning the substance from the tip of the extrusion element by an electric field extraction of the substance from the tip into the controlled gaseous environment.
    Type: Application
    Filed: April 8, 2004
    Publication date: October 13, 2005
    Applicant: Research Triangle Institute
    Inventors: Anthony Andrady, David Ensor
  • Patent number: 6951635
    Abstract: Zinc oxide-based sorbents, and processes for preparing and using them are provided, wherein the sorbents are preferably used to remove one or more reduced sulfur species from gas streams. The sorbents contain an active zinc component, optionally in combination with one or more promoter components and/or one or more substantially inert components. The active zinc component is a two phase material, consisting essentially of a zinc oxide (ZnO) phase and a zinc aluminate (ZnAl2O4) phase. Each of the two phases is characterized by a relatively small crystallite size of typically less than about 500 Angstroms. Preferably the sorbents are prepared by converting a precursor mixture, containing a precipitated zinc oxide precursor and a precipitated aluminum oxide precursor, to the two-phase, active zinc oxide containing component.
    Type: Grant
    Filed: September 26, 2003
    Date of Patent: October 4, 2005
    Assignee: Research Triangle Institute
    Inventors: Santosh Kumar Gangwal, Brian Scott Turk, Raghubir Prasad Gupta
  • Publication number: 20050197360
    Abstract: A class of binding ligands for cocaine receptors and other receptors in the brain. Specifically, a novel family of compounds shows high binding specificity and activity, and, in a radiolabeled form, can be used to bind to these receptors, for biochemical assays and imaging techniques. Such imaging is useful for determining effective doses of new drug candidates in human populations. In addition, the high specificity, slow onset and long duration of the action of these compounds at the receptors makes them particularly well suited for therapeutic uses, for example as substitute medication for psychostimulant abuse. Some of these compounds may be useful in treating Parkinson's Disease or depression, by virtue of their inhibitory properties at monoamine transporters.
    Type: Application
    Filed: November 12, 2004
    Publication date: September 8, 2005
    Applicant: Research Triangle Institute
    Inventors: Michael Kuhar, Frank Carroll, John Boja, Anita Lewin, Philip Abraham
  • Patent number: 6907130
    Abstract: A apparatus and method for inner ear implants is provided that generates signal processing stochastic independence activity across the excited neural population. A high rate pulse train can produce random spike patterns in auditory nerve fibers (hereafter “pseudospontaneous activity”) that are statistically similar to those produced by spontaneous activity in the normal auditory nerve. We call this activity “pseudospontaneous”. Varying rates of pseudospontaneous activity can be created by varying the intensity of a fixed amplitude, high rate pulse train stimulus, e.g., 5000 pps. The high rate pulse train can desynchronize the nerve fiber population and can be combined with a data signal in an inner ear implant. The pseudospontaneous activity can enhance neural representation of temporal detail and dynamic range with an inner ear implant such as a cochlear implant. The pseudospontaneous activity can further eliminate a major difference between acoustic-and electrical-derived hearing percepts.
    Type: Grant
    Filed: February 13, 1998
    Date of Patent: June 14, 2005
    Assignees: University of Iowa Research Foundation, Research Triangle Institute
    Inventors: Jay Rubinstein, Blake Wilson
  • Patent number: 6900228
    Abstract: The present application relates to novel opioid receptor antagonists and agonists, methods of making these compounds, and methods of use thereof.
    Type: Grant
    Filed: March 9, 1999
    Date of Patent: May 31, 2005
    Assignee: Research Triangle Institute
    Inventors: Frank I. Carroll, James B. Thomas, S. Wayne Mascarella
  • Publication number: 20050096338
    Abstract: Camptothecin analogs having an E-ring ketone are effective anti tumor compounds. These compounds inhibit the enzyme topoisomerase I and may alkylate DNA of the associated topoisomerase I DNA cleavable complex.
    Type: Application
    Filed: December 17, 2004
    Publication date: May 5, 2005
    Applicant: Research Triangle Institute
    Inventors: Monroe Wall, Mansukh Wani, Govindarajan Manikumar, Michael Wall
  • Publication number: 20050070430
    Abstract: The disclosure relates to zinc oxide-based sorbents, and processes for preparing and using them. The sorbents are preferably used to remove one or more reduced sulfur species from gas streams. The sorbents comprise an active zinc component, optionally in combination with one or more promoter components and/or one or more substantially inert components. The active zinc component is a two phase material, consisting essentially of a zinc oxide (ZnO) phase and a zinc aluminate (ZnAl2O4) phase. Each of the two phases is characterized by a relatively small crystallite size of typically less than about 500 Angstroms. Preferably the sorbents are prepared by converting a precursor mixture, comprising a precipitated zinc oxide precursor and a precipitated aluminum oxide precursor, to the two-phase, active zinc oxide containing component.
    Type: Application
    Filed: September 26, 2003
    Publication date: March 31, 2005
    Applicant: Research Triangle Institute
    Inventors: Santosh Gangwal, Brian Turk, Raghubir Gupta
  • Patent number: 6864248
    Abstract: An androgenic steroid compound of the formula: wherein: X, Y, Z, R1, R2, R3, R5 and R6 are as defined herein.
    Type: Grant
    Filed: November 4, 2003
    Date of Patent: March 8, 2005
    Assignee: Research Triangle Institute
    Inventors: C. Edgar Cook, John A. Kepler, Yue-Wei Lee, Mansukh C. Wani
  • Publication number: 20040266804
    Abstract: Camptothecin analogs having an E-ring ketone are effective anti tumor compounds. These compounds inhibit the enzyme topoisomerase I and may alkylate DNA of the associated topoisomerase I DNA cleavable complex.
    Type: Application
    Filed: June 30, 2003
    Publication date: December 30, 2004
    Applicant: Research Triangle Institute
    Inventors: Monroe E. Wall, Mansukh C. Wani, Govindarajan Manikumar, Michael A. Wall